Hall, F., de Freitas, H. M., Kerr, C., Ito, T., Nafees, B., Lloyd, A. J., . . . Pham, T. P. (2019). Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events. Quality of Life Research, 28(5), 1191. https://doi.org/10.1007/s11136-019-02117-9
Chicago Style (17th ed.) CitationHall, F., et al. "Estimating Utilities/disutilities for High-risk Metastatic Hormone-sensitive Prostate Cancer (mHSPC) and Treatment-related Adverse Events." Quality of Life Research 28, no. 5 (2019): 1191. https://doi.org/10.1007/s11136-019-02117-9.
MLA (9th ed.) CitationHall, F., et al. "Estimating Utilities/disutilities for High-risk Metastatic Hormone-sensitive Prostate Cancer (mHSPC) and Treatment-related Adverse Events." Quality of Life Research, vol. 28, no. 5, 2019, p. 1191, https://doi.org/10.1007/s11136-019-02117-9.